On Monday, Following Stocks were among the “Top 100 Losers” of U.S. Stock Market: CSX (NYSE:CSX), Synergy Resources (NYSEMKT:SYRG), Atmel (NASDAQ:ATML), Vertex Pharmaceuticals (NASDAQ:VRTX)
CSX Corporation (NYSE:CSX) shares picked down -4.15%, and closed at $33.70. The stock volatility for the week is 2.09%, while for the month remained 1.55%. The company holds consensus target price of $37.17.
If we consider EPS growth of the company, then the company indicated the following observations:
The company showed 1.93 diluted EPS growth for trailing twelve months. However, YTD EPS growth remained 4.90% and Annual EPS growth for the past 5 years is considered as 15.10%.
The mean recommendation of analysts for this stock is 2.30. (Where 1=Buy, 5=Sale).
CSX Corporation (CSX) together with its subsidiaries, provides rail-based transportation services in the United States and Canada. It offers traditional rail services, and transports intermodal containers and trailers. The company transports crushed stone, sand and gravel, metal, phosphate, fertilizer, food, consumer, agricultural, automotive, paper, and chemical products; and coal, coke, and iron ore to electricity-generating power plants, steel manufacturers, and industrial plants, as well as exports coal to deep-water port facilities.
Synergy Resources Corp (NYSEMKT:SYRG) decreased -4.08%, and closed at $11.29. The stock has price to sale ratio of 9.20, however, price to book ratio is 2.84. With recent decline, the year-to-date (YTD) performance reflected a -9.32% decline below last year. During the past month the stock lose -0.96%, bringing three-month performance to -13.22% and six-month performance to -9.24%. The mean recommendation of analysts for this stock is 1.80 (where 1=Buy, 5=Sale).
Synergy Resources Corp (NYSEMKT:SYRG) engages in the acquisition, development, exploitation, exploration, and production of oil and natural gas properties primarily located in the Denver-Julesburg Basin in northeast Colorado. It holds interests in the Wattenberg field covering approximately 31,000 net developed and undeveloped acres located in Colorado; and Northern Extension area covering approximately 26,000 undeveloped acres.
Atmel Corporation (NASDAQ:ATML) decreased -4.01%, and closed at $8.61. The company holds the market capitalization of $3.73 B. For the last twelve months, the stock was able to keep return on equity at 3.60%, while return on assets at 2.40%, in response to its return on investment at 3.90%. Its 20-day moving average gained 0.27%, Above 50-day moving average of 2.50%, above 200-day moving average of 4.00% from the latest market price of $8.61. The mean recommendation of analysts for this stock is 2.30. (Where 1=Buy, 5=Sale).
Atmel Corporation (ATML) designs, develops, manufactures, and sells semiconductor integrated circuit products primarily in the United States, Asia, Europe, South Africa, and Central and South America. It operates in four segments: Microcontroller, Nonvolatile Memory, Automotive, and Multi-Market and Other.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) fell -3.98%, and closed at $125.79. The stock has the beta value of 0.32, and its volatility for the week is 3.63%, while for the month it is 3.17%. The company has the market capitalization of $31.71 billion. The company holds the book value per share of 4.51, whereas cash per share is 5.73. Price to book ratio remained 27.89, while price to sale ratio is 52.47. Analysts mean recommendation for the stock is said to be 2.20 (where 1=Buy, 5=sale).
Vertex Pharmaceuticals Incorporated (VRTX) engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. The company focuses on developing and commercializing therapies for the treatment of cystic fibrosis (CF); and advancing its research and early-stage development programs.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The data demonstrated in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
